Patents Assigned to Arris Pharmaceutical
  • Patent number: 5736357
    Abstract: The invention relates to cathepsin O proteins, nucleic acids, and antibodies.
    Type: Grant
    Filed: October 27, 1994
    Date of Patent: April 7, 1998
    Assignee: Arris Pharmaceutical
    Inventors: Dieter Bromme, Kathleen Okamoto
  • Patent number: 5591646
    Abstract: Method and apparatus for simple and rapid preparation of reusable, addressable surface-immobilized arrays of biomolecules (libraries) used for screening for interaction with any biologically significant target. A special plate having on its surface a plurality of discreet functionalized substrate areas, typically in arrays of 10.times.10 to 400.times.400, is provided for chemical synthesis or bonding thereon of desired families of biomolecules (e.g. peptides, DNA, RNA, oligosaccharides). In the case of peptides, such as hexapeptides, the resulting permanently hexapeptide-loaded plate is a reusable Addressable Synthetic Peptide Combinatorial Library (ASPCL), in which 1 to 3 (typically two) of the positions in the sequence are uniquely identified by the address location. Plate embodiments include substrates of physically bonded (e.g.
    Type: Grant
    Filed: September 2, 1992
    Date of Patent: January 7, 1997
    Assignee: Arris Pharmaceutical
    Inventors: Derek Hudson, Charles R. Johnson, Lutz Giebel